Trends in clinical trial investigator workforce and turnover: An analysis of the U.S. FDA 1572 BMIS database
Background: High turnover rates among clinical trial investigators contribute to inefficiency, instability, and increased costs for the clinical research enterprise; however, factors contributing to investigator turnover have not been well characterized. Methods: Using information from the U.S. Food...
Main Authors: | Christopher B. Fordyce, Matthew T. Roe, Christine Pierre, Terri Hinkley, Gerrit Hamre, Pamela Tenaerts, Jonathan McCall, James D. Topping |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Contemporary Clinical Trials Communications |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865418301315 |
Similar Items
-
Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials
by: Carrie B. Dombeck, et al.
Published: (2020-03-01) -
One and done: Reasons principal investigators conduct only one FDA-regulated drug trial
by: Amy Corneli, PhD, MPH, et al.
Published: (2017-06-01) -
Women develop diabetes at higher BMIs than men
by: Sourij, H, et al.
Published: (2012) -
Women develop diabetes at higher BMIs than men.
by: Sourij, H, et al.
Published: (2012) -
Ultra-low cost eyetracking as an high-information throughput alternative to BMIs
by: Aldo Faisal A, et al.
Published: (2011-07-01)